• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒学中的类器官

Organoids in virology.

作者信息

Chu Julie T S, Lamers Mart M

机构信息

Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.

出版信息

Npj Viruses. 2024 Feb 7;2(1):5. doi: 10.1038/s44298-024-00017-5.

DOI:10.1038/s44298-024-00017-5
PMID:40295690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11721363/
Abstract

To adequately prepare against imminent disease outbreaks from diverse and ever-changing viral pathogens, improved experimental models that can accurately recapitulate host-virus responses and disease pathogenesis in human are essential. Organoid platforms have emerged in recent years as amenable in vitro tools that can bridge the limitations of traditional 2D cell lines and animal models for viral disease research. We highlight in this review the key insights that have contributed by organoid models to virus research, the limitations that exist in current platforms, and outline novel approaches that are being applied to address these shortcomings.

摘要

为了充分防范来自多样且不断变化的病毒病原体的疾病爆发,改进能够准确模拟人类宿主-病毒反应和疾病发病机制的实验模型至关重要。近年来,类器官平台已成为适用的体外工具,可弥补传统二维细胞系和动物模型在病毒疾病研究方面的局限性。在本综述中,我们重点介绍了类器官模型对病毒研究的关键贡献、当前平台存在的局限性,并概述了为解决这些不足而正在应用的新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2725/11721363/948215905fe4/44298_2024_17_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2725/11721363/9142cd706263/44298_2024_17_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2725/11721363/d01afbe92159/44298_2024_17_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2725/11721363/948215905fe4/44298_2024_17_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2725/11721363/9142cd706263/44298_2024_17_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2725/11721363/d01afbe92159/44298_2024_17_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2725/11721363/948215905fe4/44298_2024_17_Fig3_HTML.jpg

相似文献

1
Organoids in virology.病毒学中的类器官
Npj Viruses. 2024 Feb 7;2(1):5. doi: 10.1038/s44298-024-00017-5.
2
3D Human Organoids: The Next "Viral" Model for the Molecular Basis of Infectious Diseases.3D人体类器官:传染病分子基础的下一个“热门”模型。
Biomedicines. 2022 Jun 28;10(7):1541. doi: 10.3390/biomedicines10071541.
3
Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus.人器官型气道和肺泡分化的肺类器官细胞允许流感和 SARS-CoV-2 呼吸道病毒感染。
Front Cell Infect Microbiol. 2022 Mar 14;12:841447. doi: 10.3389/fcimb.2022.841447. eCollection 2022.
4
Vascularised organoids: Recent advances and applications in cancer research.血管化类器官:癌症研究中的最新进展与应用
Clin Transl Med. 2025 Mar;15(3):e70258. doi: 10.1002/ctm2.70258.
5
Human Organoids and Organs-on-Chips for Addressing COVID-19 Challenges.用于应对 COVID-19 挑战的人类类器官和器官芯片。
Adv Sci (Weinh). 2022 Apr;9(10):e2105187. doi: 10.1002/advs.202105187. Epub 2022 Feb 2.
6
Modeling Host-Virus Interactions in Viral Infectious Diseases Using Stem-Cell-Derived Systems and CRISPR/Cas9 Technology.利用干细胞衍生系统和 CRISPR/Cas9 技术对病毒性传染病中的宿主-病毒相互作用进行建模。
Viruses. 2019 Jan 30;11(2):124. doi: 10.3390/v11020124.
7
Human cerebral organoids - a new tool for clinical neurology research.人类大脑类器官——临床神经病学研究的新工具。
Nat Rev Neurol. 2022 Nov;18(11):661-680. doi: 10.1038/s41582-022-00723-9. Epub 2022 Oct 17.
8
Human Nasal Organoids Model SARS-CoV-2 Upper Respiratory Infection and Recapitulate the Differential Infectivity of Emerging Variants.人鼻腔类器官模型模拟 SARS-CoV-2 上呼吸道感染并重现新兴变异株的差异感染性。
mBio. 2022 Aug 30;13(4):e0194422. doi: 10.1128/mbio.01944-22. Epub 2022 Aug 8.
9
Vascularized tissue on mesh-assisted platform (VT-MAP): a novel approach for diverse organoid size culture and tailored cancer drug response analysis.基于网状辅助平台的血管化组织(VT-MAP):一种用于培养不同大小类器官和定制癌症药物反应分析的新方法。
Lab Chip. 2024 Apr 16;24(8):2208-2223. doi: 10.1039/d3lc01055d.
10
Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.使用诱导多能干细胞研究人类神经紊乱:从 2D 单层到 3D 类器官和血脑屏障模型。
Compr Physiol. 2019 Mar 14;9(2):565-611. doi: 10.1002/cphy.c180025.

引用本文的文献

1
Current status and future prospects of toxicity assessment using organoids.使用类器官进行毒性评估的现状与未来展望。
Toxicol Res. 2025 Jun 13;41(4):325-333. doi: 10.1007/s43188-025-00298-9. eCollection 2025 Jul.

本文引用的文献

1
A multicellular liver organoid model for investigating hepatitis C virus infection and nonalcoholic fatty liver disease progression.用于研究丙型肝炎病毒感染和非酒精性脂肪性肝病进展的多细胞肝类器官模型。
Hepatology. 2024 Jul 1;80(1):186-201. doi: 10.1097/HEP.0000000000000683. Epub 2023 Nov 16.
2
Identification of CCZ1 as an essential lysosomal trafficking regulator in Marburg and Ebola virus infections.鉴定 CCZ1 为马尔堡和埃博拉病毒感染中必需的溶酶体运输调节剂。
Nat Commun. 2023 Oct 25;14(1):6785. doi: 10.1038/s41467-023-42526-6.
3
SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models.
SARS-CoV-2 奥密克戎变体的进入是通过人类气道和肠类器官模型中的 II 型跨膜丝氨酸蛋白酶介导的。
J Virol. 2023 Aug 31;97(8):e0085123. doi: 10.1128/jvi.00851-23. Epub 2023 Aug 9.
4
Influenza vaccine format mediates distinct cellular and antibody responses in human immune organoids.流感疫苗剂型在人类免疫类器官中介导不同的细胞和抗体反应。
Immunity. 2023 Aug 8;56(8):1910-1926.e7. doi: 10.1016/j.immuni.2023.06.019. Epub 2023 Jul 20.
5
Land-use change and the livestock revolution increase the risk of zoonotic coronavirus transmission from rhinolophid bats.土地利用变化和畜牧业革命增加了菊头蝠传播人畜共患冠状病毒的风险。
Nat Food. 2021 Jun;2(6):409-416. doi: 10.1038/s43016-021-00285-x. Epub 2021 May 31.
6
The FDA Modernization Act 2.0: Drug Testing in Animals is Rendered Optional.《美国食品药品监督管理局2.0版现代化法案》:动物实验检测变为可选项。
Am J Med. 2023 Sep;136(9):853-854. doi: 10.1016/j.amjmed.2023.03.033. Epub 2023 Apr 18.
7
Development of a screening platform to discover natural products active against SARS-CoV-2 infection using lung organoid models.利用肺类器官模型开发一个筛选平台,以发现对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染有活性的天然产物。
Biomater Res. 2023 Mar 1;27(1):18. doi: 10.1186/s40824-023-00357-y.
8
hPSC-derived lung organoids: Potential opportunities and challenges.人多能干细胞来源的肺类器官:潜在机遇与挑战。
Heliyon. 2023 Feb 4;9(2):e13498. doi: 10.1016/j.heliyon.2023.e13498. eCollection 2023 Feb.
9
SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming.SARS-CoV-2 在气道上皮细胞中的复制需要纤毛的运动和微绒毛的重编程。
Cell. 2023 Jan 5;186(1):112-130.e20. doi: 10.1016/j.cell.2022.11.030. Epub 2022 Dec 2.
10
Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study.荷兰 COVID-19 后躯体症状的持续存在:一项观察性队列研究。
Lancet. 2022 Aug 6;400(10350):452-461. doi: 10.1016/S0140-6736(22)01214-4.